Your browser doesn't support javascript.
loading
Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With NTRK Fusion-Positive Solid Tumors.
Demetri, George D; De Braud, Filippo; Drilon, Alexander; Siena, Salvatore; Patel, Manish R; Cho, Byoung Chul; Liu, Stephen V; Ahn, Myung-Ju; Chiu, Chao-Hua; Lin, Jessica J; Goto, Koichi; Lee, Jeeyun; Bazhenova, Lyudmila; John, Thomas; Fakih, Marwan; Chawla, Sant P; Dziadziuszko, Rafal; Seto, Takashi; Heinzmann, Sebastian; Pitcher, Bethany; Chen, David; Wilson, Timothy R; Rolfo, Christian.
Afiliación
  • Demetri GD; Dana-Farber Cancer Institute and Ludwig Center at Harvard Medical School, Boston, Massachusetts.
  • De Braud F; Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Drilon A; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.
  • Siena S; Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College, New York, New York.
  • Patel MR; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.
  • Cho BC; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Liu SV; Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
  • Ahn MJ; Yonsei Cancer Hospital, Seoul, Republic of Korea.
  • Chiu CH; Georgetown University, Washington, D.C.
  • Lin JJ; Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Goto K; Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Lee J; Massachusetts General Hospital, Boston, Massachusetts.
  • Bazhenova L; National Cancer Center Hospital East, Kashiwa, Japan.
  • John T; Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Fakih M; University of California San Diego, San Diego, California.
  • Chawla SP; Peter MacCallum Cancer Center, and Olivia Newton-John Cancer Centre, Austin Health, Melbourne, Australia.
  • Dziadziuszko R; City of Hope Comprehensive Cancer Center, Duarte, California.
  • Seto T; Sarcoma Oncology Center, Santa Monica, California.
  • Heinzmann S; Department of Oncology and Radiotherapy and Early Clinical Trials Unit, Medical University of Gdansk, Gdansk, Poland.
  • Pitcher B; National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Chen D; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Wilson TR; F. Hoffmann-La Roche Ltd, Mississauga, Canada.
  • Rolfo C; Genentech Inc., South San Francisco, California.
Clin Cancer Res ; 28(7): 1302-1312, 2022 04 01.
Article en En | MEDLINE | ID: mdl-35144967
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Límite: Adult / Child / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Límite: Adult / Child / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article